Randomized controlled trials are the ‘gold standard’ of research — but a difficult fit for trans care
“Maybe the larger question is, would anything be enough? For certain audiences, governments, leaders, it doesn't matter what the research says. It's almost irrelevant.”
In order to provide gender-affirming care, clinicians must sometimes jump through unusual hoops.
In Australia, for example, the government won’t subsidize testosterone treatment for a trans man without a peculiar bureaucratic maneuver; a doctor must say the patient has a testicular disorder. The disorder: Trans men, being trans, are born without testes.
What's Your Reaction?
